Seno Medical Instruments Completes Patient Enrollment in U.S. Pivotal Study of Imagio® Breast Imaging System

SAN ANTONIO, Sept. 23, 2014 /PRNewswire/ -- Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, announced today it has completed active enrollment of subjects in its U.S.-based PIONEER Pivotal Study of Imagio®. The study was designed to determine if this technology will provide ...



from Content Keyword RSS http://ift.tt/1ofWLOV

via IFTTT